These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 11827681)

  • 1. Tissue factor and coronary artery disease.
    Moons AH; Levi M; Peters RJ
    Cardiovasc Res; 2002 Feb; 53(2):313-25. PubMed ID: 11827681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of tissue factor/factor VIIa in the pathophysiology of acute thrombotic formation.
    Girard TJ; Nicholson NS
    Curr Opin Pharmacol; 2001 Apr; 1(2):159-63. PubMed ID: 11714090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hirudin reduces tissue factor expression in neointima after balloon injury in rabbit femoral and porcine coronary arteries.
    Gertz SD; Fallon JT; Gallo R; Taubman MB; Banai S; Barry WL; Gimple LW; Nemerson Y; Thiruvikraman S; Naidu SS; Chesebro JH; Fuster V; Sarembock IJ; Badimon JJ
    Circulation; 1998 Aug; 98(6):580-7. PubMed ID: 9714116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue factor in atherosclerosis.
    Tremoli E; Camera M; Toschi V; Colli S
    Atherosclerosis; 1999 Jun; 144(2):273-83. PubMed ID: 10407489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue factor in acute coronary syndromes.
    Ott I
    Semin Vasc Med; 2003 May; 3(2):185-92. PubMed ID: 15199481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue factor - a therapeutic target for thrombotic disorders.
    Houston DS
    Expert Opin Ther Targets; 2002 Apr; 6(2):159-74. PubMed ID: 12223078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherosclerotic plaque rupture and thrombosis. Evolving concepts.
    Fuster V; Stein B; Ambrose JA; Badimon L; Badimon JJ; Chesebro JH
    Circulation; 1990 Sep; 82(3 Suppl):II47-59. PubMed ID: 2203564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wall passivation for unstable angina.
    Lettino M; Dailey-Sterling F; Badimon L; Chesebro JH; Badimon JJ
    Semin Interv Cardiol; 1996 Mar; 1(1):60-6. PubMed ID: 9552495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of acute coronary syndromes.
    Schulman SP; Fessler HE
    Am J Respir Crit Care Med; 2001 Sep; 164(6):917-22. PubMed ID: 11587971
    [No Abstract]   [Full Text] [Related]  

  • 10. Atherothrombosis: role of tissue factor; link between diabetes, obesity and inflammation.
    Meerarani P; Moreno PR; Cimmino G; Badimon JJ
    Indian J Exp Biol; 2007 Jan; 45(1):103-10. PubMed ID: 17249334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The importance of thrombin and its inhibition in unstable angina. Nonfractionated heparin, hirudin and defractionated heparins].
    López-Sendón J; López de Sá E; Rubio Sanz R; Delcán Domínguez JL
    Rev Esp Cardiol; 1999; 52 Suppl 1():76-89. PubMed ID: 10364817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation for acute coronary syndromes: from heparin to direct thrombin inhibitors.
    Lepor NE
    Rev Cardiovasc Med; 2007; 8 Suppl 3():S9-17. PubMed ID: 17917621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant nematode anticoagulant protein c2, an inhibitor of the tissue factor/factor VIIa complex, in patients undergoing elective coronary angioplasty.
    Moons AH; Peters RJ; Bijsterveld NR; Piek JJ; Prins MH; Vlasuk GP; Rote WE; Büller HR
    J Am Coll Cardiol; 2003 Jun; 41(12):2147-53. PubMed ID: 12821239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue factor as a therapeutic target in coronary syndromes.
    Banai S; Gertz SD
    Am J Cardiol; 2001 Mar; 87(6):763-5. PubMed ID: 11249899
    [No Abstract]   [Full Text] [Related]  

  • 15. Tissue factor in the pathogenesis of atherosclerosis.
    Taubman MB; Fallon JT; Schecter AD; Giesen P; Mendlowitz M; Fyfe BS; Marmur JD; Nemerson Y
    Thromb Haemost; 1997 Jul; 78(1):200-4. PubMed ID: 9198153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Programmed cellular death and atherogenesis: from molecular mechanisms to clinical aspects].
    Lesauskaite V; Ivanoviene L; Valanciūte A
    Medicina (Kaunas); 2003; 39(6):529-34. PubMed ID: 12829874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors, angiotensin-converting enzyme inhibitors, cyclooxygenase-2 inhibitors, and aspirin in anti-inflammatory and immunomodulatory treatment of cardiovascular diseases.
    Schieffer B; Drexler H
    Am J Cardiol; 2003 Jun; 91(12A):12H-18H. PubMed ID: 12818730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathophysiology of acute coronary syndromes].
    Ogawa H
    J Cardiol; 1999 Mar; 33 Suppl 1():9-16. PubMed ID: 10342131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue factor and atherothrombosis.
    Saha D; S S; Sergeeva EG; Ionova ZI; Gorbach AV
    Curr Pharm Des; 2015; 21(9):1152-7. PubMed ID: 25312727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plaque rupture, thrombosis, and therapeutic implications.
    Fuster V; Badimon J; Chesebro JH; Fallon JT
    Haemostasis; 1996 Oct; 26 Suppl 4():269-84. PubMed ID: 8979133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.